Maze Therapeutics has dosed the first subject in the Phase II HORIZON study to evaluate its oral apolipoprotein L1 (APOL1) ...

Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company harnessing the power of human genetics to ...

and steroid resistant nephrotic syndrome (SRNS). Although the prevalence of HTN in SSNS is less documented than in SRNS, recent studies reported high prevalence in both. Studies have estimated the ...

Nephrotic syndrome is characterized by high levels of protein in the urine, low blood protein levels, swelling, and increased cholesterol levels. The use of ACTH, a hormone produced by the ...

A typical platelet count range can change with age. Platelet counts may fluctuate due to natural vascular aging, changes in bone marrow tissue, and altered blood plasma makeup. Platelets ...

Maze Therapeutics, Inc. (NASDAQ: MAZE), a clinical-stage biopharmaceutical company with a market capitalization of $569 million, has dosed the first patient in its Phase 2 HORIZON Study of MZE829, ...

Likewise, Amazon's Elements line of products are only available to Prime members. The product line ranges from baby wipes to vitamins. The idea is that Amazon goes the extra mile of telling you ...

For those who want to eat a low-carbon diet that is also nutritious, getting the right level of protein can be challenging. The picture is complicated by the huge range of products available to us ...

Scroll through TikTok or Instagram and you’ll be inundated with protein-centric recipes. Maximizing protein is a huge trend right now on social media—and not just in the usual suspects ...

Only 5 patients with azotemia and proteinuria were found to have no lysozymuria. One of these 5 patients had severe uremia but was oliguric, 1 had nephrotic syndrome with minimal azotemia ...